Please assess the completion status of the following clinical trial:

Trial Title: Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 30 to 80 years Reversible ischemia on a stress SPECT Angina pectoris CCS class \>_ 2 Reduced exercise time \< 10 min No further revascularization options~Exclusion Criteria:~* Pregnant Present or history of cancer Proliferative retinopathy Systemic severe disease LVEF \< 25 % NYHA \> II

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Mesenchymal stromal cell (Type: ACTIVE_COMPARATOR): Mesenchymal stromal cell

Based on this trial design, predict the completion outcome and termination type (if applicable).